secwatch.observer — SEC 8-K summary
======================================

Issuer:     UPEXI, INC. (UPXI)
CIK:        0001775194
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001477932-22-008060
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Upexi sells select CBD assets for $23.5M; reiterates FY2023 revenue guidance $72-82M
--------------------------------------------------------------------------------

- Sold 100% of Infusionz LLC to Bloomios for ~$23.5M in cash, convertible note, preferred stock, debenture, and warrants.
- Received $5.5M cash at closing, plus $9.5M loan receivables and $8.5M in Bloomios preferred equity.
- Reiterated FY2023 revenue guidance of $72-82M; expects to issue capital plan update by Nov 14, 2022.
- Obtained $3M, 10-year mortgage at 4.8% on Florida HQ to reduce short-term acquisition loans.
- Sold CBD assets originally acquired for ~$6.3M, reflecting value growth via partnerships and organic growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1775194/000147793222008060/0001477932-22-008060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1775194/000147793222008060/upxi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-008060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer